Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Röllig

Showing results (1-10 of 190) with videos related to

Pageof 19
Sort By:
Hematology. American Society of Hematology. Education Program|December 9, 2023
Improving long-term outcomes with intensive induction chemotherapy for patients with AMLChristoph Röllig
Blood|November 16, 2023
Gemtuzumab ozogamicin in AML: the next chapterChristoph Röllig
Der Internist|February 16, 2019
[Diagnosis and treatment of acute myeloid leukemia : The updated 2018 Onkopedia Guideline]Christoph Röllig
Blood|July 31, 2025
Magrolimab and the tale of indigestible AMLChristoph Röllig
Blood|March 18, 2015
How I treat hyperleukocytosis in acute myeloid leukemiaChristoph Röllig, Gerhard Ehninger
Cancer Treatment Reviews|May 26, 2009
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic reviewChristoph Röllig, Thomas Illmer
The Lancet. Oncology|June 9, 2019
Oral targeted agent versus chemotherapy in acute myeloid leukaemiaChristoph Röllig, Wolfgang E Berdel
Lancet (London, England)|December 27, 2014
Multiple myelomaChristoph Röllig, Stefan Knop, Martin Bornhäuser
Chemotherapy|February 12, 2020
Treatment of Pegylated Asparaginase-Induced Hypertriglyceridemia with Continuous Intravenous Infusion of Insulin and Heparin: A Case ReportNael Alakel, Sandra Heuschkel, Ekaterina Balaian, et al.
Haematologica|October 10, 2009
Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxideFriedrich Stölzel, Martin Wermke, Christoph Röllig, et al.
Pageof 19

Showing results (1-10 of 190) with videos related to

Sort By:
Pageof 19
Hematology. American Society of Hematology. Education Program|December 9, 2023
Improving long-term outcomes with intensive induction chemotherapy for patients with AMLChristoph Röllig
Blood|November 16, 2023
Gemtuzumab ozogamicin in AML: the next chapterChristoph Röllig
Der Internist|February 16, 2019
[Diagnosis and treatment of acute myeloid leukemia : The updated 2018 Onkopedia Guideline]Christoph Röllig
Blood|July 31, 2025
Magrolimab and the tale of indigestible AMLChristoph Röllig
Blood|March 18, 2015
How I treat hyperleukocytosis in acute myeloid leukemiaChristoph Röllig, Gerhard Ehninger
Cancer Treatment Reviews|May 26, 2009
The efficacy of arsenic trioxide for the treatment of relapsed and refractory multiple myeloma: a systematic reviewChristoph Röllig, Thomas Illmer
The Lancet. Oncology|June 9, 2019
Oral targeted agent versus chemotherapy in acute myeloid leukaemiaChristoph Röllig, Wolfgang E Berdel
Lancet (London, England)|December 27, 2014
Multiple myelomaChristoph Röllig, Stefan Knop, Martin Bornhäuser
Chemotherapy|February 12, 2020
Treatment of Pegylated Asparaginase-Induced Hypertriglyceridemia with Continuous Intravenous Infusion of Insulin and Heparin: A Case ReportNael Alakel, Sandra Heuschkel, Ekaterina Balaian, et al.
Haematologica|October 10, 2009
Mobilization of PML/RARalpha negative peripheral blood stem cells with a combination of G-CSF and CXCR4 blockade in relapsed acute promyelocytic leukemia pre-treated with arsenic trioxideFriedrich Stölzel, Martin Wermke, Christoph Röllig, et al.
Pageof 19